Estee Lauder Leads Wednesday Stock Movers as Earnings Beats and Deal News Drive Gains

Estee Lauder was the standout mover on Wednesday, with shares jumping more than 15% after the beauty conglomerate reported fiscal fourth-quarter revenue of $3.6 billion, up 6% year over year, beating Wall Street estimates and ending three consecutive years of annual revenue declines. The company also raised its profit margin outlook for fiscal 2027, signaling that its turnaround efforts are gaining traction. Webull (BULL) climbed 7% to $8.49 ahead of its Q2 2026 earnings report, with sentiment buoyed by a surge in Bitcoin and broader crypto enthusiasm; Robinhood (HOOD) gained a similar 7% to $98.45 as CEO Vlad Tenev pressed U.S. regulators to approve tokenized securities.

ZeroStack (ZSTK) surged after announcing a $1.0 billion strategic contribution of Memecore tokens from Puple AI Inc. and Blockcat Pte. Ltd., structured as 3,500,000 common shares plus pre-funded warrants to purchase up to 36,198,293 additional shares at $25.19 per share. Ultragenyx Pharmaceutical (RARE) rose 5.2% as investors positioned ahead of an FDA decision on its DTX401 AAV gene therapy for Glycogen Storage Disease Type Ia, with a PDUFA action date set for August 23, 2026.

Notable options activity accompanied some of these moves, with Novavax (NVAX) and Talen Energy (TLN) also drawing elevated contract volumes among Russell 3000 components.